TRML   $23.01  1.28% Market Closed After Close 23.01 0.0

Tourmaline Bio Inc
Total Cash 289.53M
totalCashPerShare 11.292
EBITDA -60.98M
Total Debt 333.00K
quickRatio 45.517
currentRatio 46.868
Total Revenue
debtToEquity 0.098
Revenue/Share
ROA -0.17479
ROE -0.23277001
grossProfits
freeCashflow -36.78M
operatingCashflow -47.68M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 385.17M
forwardPE -7.535816
floatShares 12.55M
sharesOutstanding 25.64M
sharesShort 1.52M
sharesShortPriorMonth 1.97M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.23%
heldPercentInstitutions 0.85%
Short Ratio help_outline 4.76%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 13.19
Price To Book help_outline 1.99
earningsQuarterlyGrowth
netIncomeToCommon -49.29M
trailingEps -1.92%
forwardEps -3.49%
enterpriseToEbitda -6.32
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.82 3Q 2024
institutionsCount 132
lastUpdated Nov. 2, 2024, 6:41 a.m.